Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 19 2019

Full Issue

The Politics Of Purdue Pharma Settlement: Dems Want To Gamble For Larger Amount, GOP Favors Quick Resolution

Most of the 24 states rejecting the Purdue deal are led by Democrats, who will argue that the Sackler family should be held more accountable than the current settlement does. The lawyers believe that the family has taken measures to protect their own personal wealth from any fallout.

Politico: Democrats Favor Righteous Rage, GOP The Safer Bet In Purdue Opioids Settlement

Last year, 49 states and thousands of cities, counties and territories joined in massive litigation designed to punish the drug industry for its role in the opioid crisis. But now that one of the companies, Oxycontin-maker Purdue, has put as much as $12 billion on the table as part of a bankruptcy settlement, Democrats and Republicans are fighting over the proper strategy. (Karlin, 9/18)

The Washington Post: Purdue Pharma’s Bankruptcy Plan Includes Special Protection For The Sackler Family Fortune

In 2008, as Purdue Pharma was searching for a new chief executive, Richard Sackler received a memo from an adviser. “In the event that a favorable [recapitalization] deal cannot be structured during 2008, the most certain way for the owners to diversify their risk is to distribute more free cash flow to themselves,” F. Peter Boer, a member of Purdue’s board of directors told Sackler, a prominent member of the wealthy family that owns the company. (Merle and Bernstein, 9/18)

Los Angeles Times: Who's To Blame For The Nation's Opioid Crisis? Massive Trial May Answer That Question

For the families of the roughly 400,000 Americans who have died of opioid drug overdoses since 1999, a legal drama scheduled to unfold in an Ohio courtroom next month may feel like a true shot at justice. After downplaying the risks of dangerous and highly addictive prescription narcotics, and of profiting from their spiraling misuse, the purveyors of prescription painkillers could be forced to reckon with the consequences of their actions. (Healy, 9/18)

Miami Herald: Florida Families Hurt By Purdue Opioids Oppose Settlement

Purdue Pharma is facing thousands of lawsuits from states and municipalities over its role in marketing and aggressively pushing the sale of its opioids. Florida’s tentative agreement was announced Sept. 11 by Florida Attorney General Ashley Moody. Dodds told the Miami Herald that she feels betrayed by state leaders who are heading toward a settlement without talking to her and others like her. (Conarck, 9/18)

In other news on the opioid crisis —

The Star Tribune: New Minnesota Opioid Council Goes To Work 

Minnesota took a major step in a landmark push to combat opioid addiction Wednesday, assembling an independent panel of experts, advocates and lawmakers to allocate tens of millions of dollars in new funding to combat the crisis. The Opioid Epidemic Response Advisory Council, formally appointed Wednesday, will meet for the first time next week. The 19 voting members will spend the coming months making long-awaited recommendations about spending money earmarked for overdose prevention, addiction recovery, law enforcement and other services related to the epidemic. (Van Oot, 9/18)

Kaiser Health News: Doctors And Nurses With Addictions Often Denied A Crucial Recovery Option

Dr. Wesley Boyd, an associate professor of psychiatry at Harvard, has spent years working with state programs that help doctors, nurses and other health care workers who have become addicted to opioids get back on their feet professionally. He supports these non-disciplinary programs, in which doctors and nurses enroll for a number of years and are closely monitored by addiction specialists and state authorities as they seek to maintain or restore their medical licenses. (Yasinski, 9/19)

Pioneer Press: Opioid Task Force Finalized; Group To Determine How To Spend $20M To Respond To Crisis

The 19 members of an Opioid Advisory Council were finalized Wednesday ahead of the groups first meeting next week to begin to address the state’s opioid addiction crisis. The council will decide the best ways to spend an estimated $20 million a year raised from new licensing fees on drug makers and distributors. The fee and council were created by lawmakers during the legislative session that ended in May. Eleven of the 19 voting members of the council were appointed by Human Services Commissioner Jodi Harpstead. The other eight members are appointed by state statute. (Magan, 9/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF